Orthofix Medical Inc. reported $197 million in sales and $5.9 million in free cash flow for the quarter ending September 30, 2024, which met both Wall Street’s expectations and management’s guidance.
Spine Sales Lead Sales Growth
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
